Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion type Assertion NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_head.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion description "[Clearance (CL) and steady state volume of distribution (Vss) of midazolam (mean +/- SD, 95% confidence level) in cancer (424 +/- 155, 61.3 ml min(-1); 1.21 +/- 0.46, 0.18 l kg(-1)) and noncancer (407 +/- 135, 57.1 ml min(-1); 1.15 +/- 0.33, 0.155 l kg(-1)) patients, respectively, were not different and comparable with published data.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_provenance.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion evidence source_evidence_literature NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_provenance.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion SIO_000772 12630977 NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_provenance.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion wasDerivedFrom befree-20150227 NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_provenance.
- NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_assertion wasGeneratedBy ECO_0000203 NP297371.RACrTuY1jQcebbNfpMWfVmGA7QjEXjI9Vh6HTDWQ2hScM130_provenance.